Download Reactive

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
“Reactive” and Idiopathic Skin
Diseases
Rich Callahan MSPA, PA-C
Fletcher Allen Dermatology
Burlington, Vermont
ICM I – Summer 2009
Overview
• Erythema Multiforme (EM)
• Erythema Nodosum (EN)
• Stevens-Johnson Syndrome/Toxic
Epidermal Necrolysis (TEN)
• Urticaria/Angioedema
• Lichen Simplex Chronicus/Prurigo
Nodularis
• Lichen Planus
EM – What is it?
• An acute, common skin rash associated with a
number of causative factors, although 50% of the
time a precipitating cause is not found.
• Classified as a reactive, inflammatory process of
the skin, or “Hypersensitivity syndrome.”
• Reactive change in dermal vasculature with
overlying epidermal changes
EM – Epidemiology/Causative
Factors
• Can be caused by drugs, infections
(Herpes,) pregnancy, internal malignancy,
acute URI, atypical pneumonia
• ~50% idiopathic
• Mostly see in younger patients, most
common age range is 20-40 years
• I have seen several patients who develop
EM after HSV outbreaks (cold sores)
EM – Clinical Presentation
• Characteristic erythematous, target-shaped,
urticarial papules, vesicles and bullae
• Affects trunk, extremities, mucous membranes,
palms/soles.
• Lesions appear quickly in a symmetric pattern,
usually first on dorsal hands/feet, then migrating
along extensor extremities, then to trunk in severe
cases.
• Can be asymptomatic, pruritic or painful.
• Occassionally, will manifest only as oral bullae
and ulcerations.
EM – Clinical Presentation
• Eruption evolves over several days, may be
preceded by prodromal symptoms including
malaise, fever or burning/itching at sites where
EM will later develop.
• Presentation can be entirely non-diagnostic at first,
then later dx’ed as EM when classic “target
lesions” develop.
• Entire course of disease usually 1 month or less.
• Rarely life-threatening with extensive mucous
membrane involvement, patches of vesiculation,
etc
EM - Diagnosis
• EM is a clinical diagnosis based on patient history
and disease presentation.
• Skin biopsy seldom helpful in my experience as
histologic findings can be non-specific at early
stages of disease, which is when it tends to get
biopsied.
• Biopsy of target lesions generally diagnostic, but
seldom biopsied as is an easy clinical diagnosis by
that point!
EM - Treatment
• Mild cases do not require treatment.
• Moderate cases respond well to a 1-3 week
course of oral steroids (prednisone.)
• Severe cases treated with IV steroids.
• In recurrent cases with positive HSV
association, I have used prophylactic
therapy with oral antiviral meds (Valtrex)
with good success.
Erythema Nodosum – EN – What
is it?
• An acute panniculitis of the lower extremities
with diverse causes
• Considered a delayed hypersensitivity reaction to
a number of possible antigens, I.e., it is a reaction
to a concurrent disease or condition.
• Most common cause today is streptococcal
infection.
• Can be precipitated by drugs, infections,
sarcoidosis, misc. inflammatory disorders
EN - Causes
•
•
•
•
•
•
Infections
Bacterial
Fungal
Viral
GI parasites
Drugs (esp. OCP’s)
•
•
•
•
•
•
Cancer
Concomitant Disease
Sarcoidosis
IBD
Ulcerative Colitis
Crohn’s Disease
EN - Epidemiology
•
•
•
•
Women >> men. Female: Male ratio is 5:1
Peak ages of incidence are 18 – 35 years.
Extremely rare in the elderly.
Historically, much less common in the
modern area with advent of antibiotic drugs.
EN – Clinical Presentation
• Presents as development of painful red nodules,
patches and plaques, usually on lower legs, over a
period of 1-2 weeks.
• Often preceded by prodromal symptoms of fever,
malaise, arthritis and arthralgias.
• Individual lesions begin as reddish, swollen
papules on shins bilaterally, then grow into
violaceous, indurated, tender patches and plaques
which resolve in 1-2 weeks.
• Eruption can recur in crops for months to years.
EN - Treatment
• Usually resolves spontaneously w/o
treatment.
• Symptomatic relief with rest and/or
NSAID’s.
• SSKI (supersaturated potassium iodide.)
• Prednisone
• ID and treatment of precipitating cause if
possible.
Stevens-Johnson Syndrome/Toxic Epidermal
Necrolysis – What is it?
• Both names represent a spectrum of disease with
SJS being the less severe end.
• A life-threatening condition characterized by large
scale and widespread necrosis and detachment of
epidermis, affecting both skin and mucosal
surfaces of eyes (conjunctivae,) nares, mouth,
anorectal/genital areas.
• One of the few truly acute medical emergencies in
Dermatology.
SJS/TEN
• Pathophysiology not entirely understood, but
thought to be reaction in keratinocytes where cells
accumulate foreign antigen and are stimulated to
apoptosis (cell death) by T-cells.
• Large areas of epidermis become necrotic and
slough off in sheets
• Results in massive transcutaneous water loss and
usually secondary bacterial infection
SJS/TEN - Causes
• Most often caused by drugs, then infections, then
rarely by a malignancy.
• Drugs include: Sulfonamides, Bactrim/Septra,
Quinolones, Cephalosporins, acetaminophen,
phenobarbital, NSAID’s, cocaine, ginseng,
allopurinol, fluconazole, many others.
• Infections include influenza, HSV, Epstein-Barr
virus, Cat-Scratch disease, histoplasmosis
• Malignancies include carcinomas and lymphomas
SJS/TEN Spectrum of Disease
• Grade I - SJS: Less than 10% of Body
Surface Area (BSA) affected.
• Grade II - SJS/TEN Overlap: Between
10% and 30% BSA affected.
• Grade III – TEN: Greater than 30% BSA
affected.
SJS/TEN
Epidemiology/Morbidity/Mortality
• Usually seen in Caucasians, male:female ration is
2:1.
• Average patient is 20-40 years old, although
occasionally seen in infants/elderly.
• If BSA involvement 10% or less, mortality is 15% of cases. 30% or higher BSA involvement has
mortality rate between 25% and 35%
• Overall mortality for entire SJS/TEN spectrum of
disease is 15%
SJS/TEN – Clinical Presentation
• Clinically manifests as erythematous and purpuric
macules and target lesions, distributed over trunk,
palms, soles and mucosal areas. Blister formation
and sloughing/necrosis of skin follow.
• Nikolsky Sign: Pushing down on blisters causes
them to spread laterally with little resistance
• Skin rash preceded by cough/URI symptoms.
• Patients have fever, electrolyte imbalances,
eye/mucous membrane involvement, pain,
occassional lung involvement.
SJS/TEN – Clinical Presentation
• Mucosal lesions lead to widespread
epidermal sloughing and crust formation.
• Extensive disease can lead to scarring,
stricture formation and partial loss of
funcion of organ system involved.
• Eye involvement includes corneal
ulcerations and conjunctival injury which
can lead to scarring and blindness.
SJS/TEN - Treatment
• Most often a reaction to drugs, so look for
offending cause in all cases: Usually the newest
drug on a patient’s list, within 1 to 4 weeks of
starting it
• Treatments are supportive, although oral
prednisone is often used in an attempt to shorten
duration of illness.
• Other treatments include oral antihistamines,
lidocaine gargles, liquid/soft diet, Burrow’s
compresses, topical steroids to non-eroded areas,
ophthalmology consult, antibacterial therapy for
secondary infections.
Urticaria/Angioedema
• Urticaria presents as
groups of itchy,
pink/flesh-colored
wheals
• Caused by edema, or
fluid accumulation in
epidermis/superficial
dermis
• Papillary vascular
plexus
• Angioedema presents
as broad, poorlydefined areas of
swelling
• Caused by edema of
dermis and subcutis
• Deep vascular plexus
Urticaria/Angioedema
• Wide Variety of
• Physical Urticaria –
Causes:
Angioedema
• 50-60% of cases
• Infections
idiopathic
• Treatment usually
• Allergies
with antihistamines
• Drugs
and/or prednisone
• Contact urticaria
• Autoimmune and
immunologic mediated
LSC/Prurigo Nodularis
• Lichenification of skin
in direct reaction to
repeated rubbing and
scratching of skin
• Skin becomes
thickened with
accentuation of skin
markings
• Scratching becomes
pleasurable to patient
• Dome-shaped,
hyperpigmented
papules and nodules in
areas of lichenification
• Often deeply
excoriated
• Hyperplasia of
cutaneous nerves leads
to enhanced sensitivity
and pruritis
Lichen Planus (LP)
• Idiopathic eruption defined by the 4 P’s:
• Pruritic, purple, polygonal papules
• Tends to affect wrists, flexor extremities,
lumbar areas, genitals, mucosa
• Tends to last 6 months to one year
• Leaves behind deep, long-lasting
hyperpigmentation
• Presence of Wickham’s striae diagnostic